Oritavancin OverviewOritavancin, sold under the brand name Orbactiv, is a novel semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved oritavancin for treatment of acute bacterial skin and skin structure infections. Contents 1 I...
Read more Oritavancin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Oritavancin
Recent Oritavancin Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Powder: 400mg/vial
- Powder, For Injection Solution, Lyophilized Powder: 1200 Mg.
NDC Database Records for Oritavancin: (1 result)Sorted by National Drug Code
- 65293-015 Orbactiv 400 mg Intravenous Injection, Powder, Lyophilized, for Solution by The Medicines Company
Other drugs which contain Oritavancin or a similar ingredient: (1 result)
- ORBACTIV Oritavancin Diphosphate